Day: January 21, 2025

Fabrice ChouraquiPhoto of Fabrice ChouraquiLeiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated Fabrice Chouraqui to become Pharming’s new Executive Director and Chief Executive Officer, succeeding Sijmen de Vries. Pharming will nominate Mr. Chouraqui for the appointment as Executive Director and Chief Executive Officer for a term of four years at an upcoming Extraordinary General Meeting of Shareholders (EGM). Information regarding the EGM, including the notice to convene, will be shared shortly in a separate press release. Upon the appointment of Mr. Chouraqui, Sijmen de Vries will resign from the Board of Directors. To ensure a smooth hand-over of tasks and responsibilities, Mr. de Vries...

                                                                                                                                                                                        WISeKey Establishes Charity Partnerships to Provide Digital Identities and Financial Inclusion to Over One Billion People DAVOS, Switzerland – January 21, 2025 – WISeKey International Holding (“WISeKey” or the “Company”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, AI, and IoT company, today announced a groundbreaking partnership with Abraham House and the Global Financial Literacy Initiative (GFLI) during the World Economic Forum in Davos. This collaboration represents a significant step towards delivering secure digital identities and financial inclusion to over one billion unbanked individuals worldwide. The partnership aligns with Abraham...

PRESS RELEASE BPCE and Generali to Create the Largest Asset Manager in Europe by revenues and a Major Player Worldwide Milan & Paris, 21 January 2025 – Assicurazioni Generali S.p.A. (“Generali”) and BPCE today announce that they have signed a non-binding Memorandum of Understanding (“MoU”) to create a joint venture between their respective asset management operations Generali Investments Holding (“GIH”)1 and Natixis Investment Managers (“Natixis IM”). BPCE (through Natixis IM) and GIH would each own 50% of the combined business with balanced governance and control rights. Overview of the proposed joint ventureCreation of a major global champion, with €1.9 trillion2 in assets under management, ranking #9 worldwide by AUM, and the leader in asset management in Europe with €4.1bn in revenues3.Critical scale in the fast-evolving...

Ad hoc announcement under Art. 53 LRBaar (Switzerland), 21 January 2025 Based on preliminary unaudited figures, Ascom reports for fiscal year 2024 a revenue of CHF 286.7 million, which is a decline of 1.6% at constant currencies, and an EBITDA margin of around 7.5%. In a continuing challenging market environment, Ascom generated net revenue of CHF 286.7 million for fiscal year 2024 (2023: CHF 297.3 million), which reflects a decline of 1.6% at constant currencies and of 3.6% at actual currencies compared to the previous year, based on preliminary unaudited figures.  Revenue development showed a mixed picture. The best performance was achieved in the key markets Nordics, DACH, the Netherlands, and Italy, while UK and the OEM business underperformed due to lower market traction than expected and project delays in the last quarter of 2024....

Read the full press release: https://cdn-banle-intl.react.hk/wp-content/uploads/2025/01/20121108/Press-Release_CBL-International-Limited-Chairman-Featured-on-Nasdaq-Amplify.pdf KUALA LUMPUR, Malaysia, Jan. 21, 2025 (GLOBE NEWSWIRE) — CBL International Limited (NASDAQ: BANL) (the “Company” or “CBL”), the listing entity of Banle Group (“Banle” or “the Group”), is pleased to announce that its Chairman and CEO, Mr. Teck Lim Chia, was recently featured in an exclusive interview on Nasdaq’s Amplify Spotlight program. During the interview, Mr. Chia discusses the company’s adoption of sustainable fuels like B24 biofuel, which led to a nearly 96% increase in its biofuel sales in 1H2024, aligning with global decarbonization efforts. He also discussed CBL’s provision of comprehensive refueling services at over 60 ports worldwide...

VANCOUVER, British Columbia, Jan. 20, 2025 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, announces that it has granted 784,712 restricted share units (“RSUs”) and 784,712 performance share units (“PSUs”). RSU Grant The Company has awarded a total of 784,712 RSUs under its Omnibus Equity Incentive Plan to selected executives and employees. The RSUs will vest over a period ranging from one to three years from the grant date. Upon vesting, each RSU grants the holder the right to receive one common share of the Company, or, at the discretion of the Company’s Board of Directors, may be settled in cash. PSU Grant The Company has granted a total of 784,712 PSUs under its Omnibus Equity...

CALGARY, Alberta, Jan. 20, 2025 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV:CMC; OTC PINK:CWSFF) (“Cielo” or the “Company”) announces the anticipated settlement of an aggregate $1,622.413.10 (the “Aggregate Debt Amount”) in debt by way of share issuance (each a “Shares for Debt Transaction”, collectively the “Shares for Debt Transactions”), subject to the approval of the TSX Venture Exchange (the “Exchange”). The Company intends to issue a total of 15,451,545 (subject to rounding) common shares (the “Repayment Shares”) at a price of $0.105 per share. The Company has executed agreements with certain of its creditors to issue 14,480,856 of the Repayment Shares at a price of $0.105 per share to settle $1,520,490.67 of the Aggregate Debt Amount. In addition, Cielo intends to execute an agreement on the same or substantially...

WATERTOWN, Mass., Jan. 20, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, will host a conference call to discuss feedback received from its Type C meeting on bitopertin in EPP with the U.S. Food and Drug Administration (FDA). The conference call will be held on Tuesday, January 21, at 8:00 am EST. Conference Call Information Please register for the event on the Events and Presentations page of Disc’s website at https://ir.discmedicine.com/. About Bitopertin Bitopertin is an investigational, clinical-stage, orally administered inhibitor of glycine transporter 1 (GlyT1) that is designed to modulate heme biosynthesis. GlyT1 is a membrane transporter...

Streamlined organization and Provider Services segment to optimize resource allocation Provider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic priorities Proceeds from the sale will be used to reduce debt resulting in accelerated deleveraging while also increasing capital availability Divesture expected to increase Company Revenue and EBITDA Growth Rates and Cash Conversion, as well as Provider Services Revenue and EBITDA Growth Rates and Margin1 Company reports 2024 preliminary Revenue and Adjusted EBITDA, above prior guidance issued on November 1, 2024, and initiates 2025 guidance excluding Community LivingLOUISVILLE, Ky., Jan. 20, 2025 (GLOBE NEWSWIRE) — BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home...